Natera Q1 revenue $367.7M (+52% YoY), net loss narrows to $0.56/share; achieves positive cash flow

Natera, Inc.

2024-Q1 EPS reported -$0.56 revenue$367,741,000

Revenue $367.7M (+52.1% YoY); product revenue up 53.4%; gross margin 56.7% vs 38.7%.
Net loss $67.6M ($0.56/share) vs $136.9M ($1.23/share) YoY; achieved ~$3M positive cash flow.
Processed ~735,800 tests (+17.5%); oncology tests ~114,800 (+61.7%).
Launched fetal RhD NIPT test; published key data in oncology and organ health.
FY 2024 guidance: revenue $1.42B-$1.45B; gross margin 53-55%; net cash ($25M)-$25M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Natera, Inc. reported first quarter ended March 31, 2024 results: revenue $367.7 million, net income net loss of $67.6 million, EPS ($0.56) per diluted share.

Period: first quarter ended March 31, 2024
Revenue: $367.7 million
Net income: net loss of $67.6 million
EPS: ($0.56) per diluted share
Result: reported results

Exact text from the filing

First Quarter Ended March 31, 2024 Financial Results Total revenues were $367.7 million in the first quarter of 2024 compared to $241.8 million in the first quarter of 2023, an increase of 52.1%. The increase in total revenues was driven primarily by a 53.4% increase in product revenues, which were $364.7 million in the first quarter of 2024 compared to $237.8 million in the first quarter of 2023. The increase in product revenues was primarily driven by an increase in volume, as well as average selling price improvements. Natera processed approximately 735,800 tests in the first quarter of 2024, including approximately 718,700 tests accessioned in its laboratory, compared to approximately 626,200 tests processed, including approximately 607,700 tests accessioned in its laboratory, in the first quarter of 2023. In the first quarter of 2024, Natera recognized revenue on approximately 679,400 tests for which results were reported to customers in the period (tests reported), including appr

View on SEC.gov

1052 earnings releases filed in the last 30 days. Browse all earnings releases →

Natera, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-059333

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.